Overall Technical outlook

Price Summary

Vertex Pharmaceuticals Incorporated's stock started the year at 431.25, climbed to a high of 431.77, fell to 426.68, and closed -0.26% lower at 430.14, with 807938 shares traded on 2026-04-28.
Over the past 52 weeks, the stock reached a maximum price of 509.5 and a minimum price of 366.54.
29 analysts suggest that VRTX's future price will lie between 330.0 and 641.0, with an average expected price of roughly 548.4483.

Technicals

Support and Resistance: The price of 430.14 is supported at 419.89 and faces resistance at 437.15. This range suggests key levels for VRTX where the price may stabilize, with 419.89 acting as a support and 437.15 as a cap on gains.
VRTX supportResistance 0885fc
Support/Resistance for VRTX


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
VRTX aroon 0885fc
Aroon chart for Vertex Pharmaceuticals Incorporated


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
VRTX bbands 0885fc
Bolinger Bands chart for Vertex Pharmaceuticals Incorporated


Parabolic SAR: The PSAR maintains a bearish outlook for VRTX, establishing a key resistance level that could limit further gains. This ongoing bearish trend suggests that the market may struggle to overcome this resistance, keeping upward movement subdued.
VRTX psar 0885fc
Parabolic Stop and Reverse chart for Vertex Pharmaceuticals Incorporated


Stochastic: As the Stochastic K-line dips below the D-line and under 20, it points to a mildly bearish market scenario. This configuration hints at some bearish sentiment, but it is not particularly strong. Investors should remain cautious and observe the market for any further signs of a downturn.
VRTX stoch 0885fc
Stochastic chart for Vertex Pharmaceuticals Incorporated


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
VRTX trippleSMA 0885fc
Tripple SMA chart for Vertex Pharmaceuticals Incorporated


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.